Gabriella Spaltro

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Angiogenic and reparative potency of a human cardiac CD90- mesenchymal subpopulation in heart ischemic model.

Angiogenic and reparative potency of a human cardiac CD90- mesenchymal subpopulation in heart ischemic model.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: April 07, 2025

Preferential myofibroblast differentiation of cardiac mesenchymal progenitor cells in the presence of atrial fibrillation.

Preferential myofibroblast differentiation of cardiac mesenchymal progenitor cells in the presence of atrial fibrillation.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: April 21, 2017

Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).

Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).

Journal: Stem cell research

Published: April 04, 2017

Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).

Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).

Journal: Stem cell research

Published: April 04, 2017

Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells.

Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells.

Journal: Cell death & disease

Published: March 21, 2017

Physiological conditions influencing regenerative potential of stem cells.

Physiological conditions influencing regenerative potential of stem cells.

Journal: Frontiers in bioscience (Landmark edition)

Published: April 22, 2016

Metaboloepigenetics: the Emerging Network in Stem Cell Homeostasis Regulation.

Metaboloepigenetics: the Emerging Network in Stem Cell Homeostasis Regulation.

Journal: Current stem cell research & therapy

Published: July 31, 2015

Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.

Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.

Journal: BioMed research international

Published: March 19, 2015

Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesis.

Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesis.

Journal: Cytotherapy

Published: November 23, 2014

Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression.

Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression.

Journal: Journal of neurochemistry

Published: November 20, 2014

Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.

Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.

Journal: The Journal of biological chemistry

Published: April 18, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026